Phase II randomized study of Plitidepsin (Aplidin), alone or in association with L-carnitine, in patients with unresectable advanced renal cell carcinoma.

Phase II randomized study of Plitidepsin (Aplidin), alone or in association with L-carnitine, in patients with unresectable advanced renal cell carcinoma.

Item
http://www.wikidata.org/entity/Q37153399
Plitidepsin has a safe cardiac profile: a comprehensive analysis.Evaluation of plitidepsin in patients with primary myelofibrosis and post polycythemia vera/essential thrombocythemia myelofibrosis: results of preclinical studies and a phase II clinical trial.Aplidin in patients with advanced dedifferentiated liposarcomas: a French Sarcoma Group Single-Arm Phase II studyPlitidepsin (Aplidin) is a potent inhibitor of diffuse large cell and Burkitt lymphoma and is synergistic with rituximabMarine-derived angiogenesis inhibitors for cancer therapy.Plitidepsin: design, development, and potential place in therapy.Marine Antibody-Drug Conjugates: Design Strategies and Research Progress.Didemnins, tamandarins and related natural products.N-methylation of peptides and proteins: an important element for modulating biological functions.Evaluating surrogacy metrics and investigating approval decisions of progression-free survival (PFS) in metastatic renal cell cancer: a systematic review.Nano-encapsulation of plitidepsin: in vivo pharmacokinetics, biodistribution, and efficacy in a renal xenograft tumor model.Phase I study of weekly plitidepsin as 1-hour infusion combined with carboplatin in patients with advanced solid tumors or lymphomas.Starvation tactics using natural compounds for advanced cancers: pharmacodynamics, clinical efficacy, and predictive biomarkers.
P2860

Phase II randomized study of Plitidepsin (Aplidin), alone or in association with L-carnitine, in patients with unresectable advanced renal cell carcinoma.

Item
http://www.wikidata.org/entity/Q37153399
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Phase II randomized study of P ...... advanced renal cell carcinoma.
@en
Phase II randomized study of P ...... advanced renal cell carcinoma.
@nl
type
label
Phase II randomized study of P ...... advanced renal cell carcinoma.
@en
Phase II randomized study of P ...... advanced renal cell carcinoma.
@nl
prefLabel
Phase II randomized study of P ...... advanced renal cell carcinoma.
@en
Phase II randomized study of P ...... advanced renal cell carcinoma.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P932
P356
P1433
P1476
Phase II randomized study of P ...... advanced renal cell carcinoma.
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P932